Christopher Sullivan
Director of Finance/CFO bei AVALO THERAPEUTICS, INC.
Profil
Christopher Sullivan is currently the Chief Financial Officer at Avalo Therapeutics, Inc. He previously worked as a Senior Manager at Ernst & Young LLP.
Additionally, he served as a Controller at OpGen, Inc. from 2015 to 2017 and at Sucampo Pharmaceuticals LLC from 2017 to 2018.
Mr. Sullivan completed his undergraduate degree at the University of Maryland.
Aktive Positionen von Christopher Sullivan
| Unternehmen | Position | Beginn |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 14.02.2022 |
Ehemalige bekannte Positionen von Christopher Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.04.2018 |
| OPGEN, INC. | Comptroller/Controller/Auditor | 01.08.2017 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Christopher Sullivan
| University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| OPGEN, INC. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
